Search Results 41-50 of 9209 for paradisegoa

  1. A Study to Evaluate Return of Pharmacogenomic Results Through Direct-to-Consumer Online Portal: Consumer Experiences - Mayo Clinic

    About this study. The purpose of this study is to explore the experiences of consumers in receiving results on genetic risk of malignant hyperthermia and ...

  2. Shear Wave Elastograph and Contrast Enhanced Ultrasound for the Treatment of Lymphedema - Mayo Clinic

    About this study. Lymphaticovenous anstomosis is an effective surgery to treat lymphedema in the upper extremities secondary to cancer treatment.

  3. Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study About How Platelets Adhere to the Blood von Willebrand Factor in Healthy Adults - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Understand the Clinical Characteristics and to Identify Gene(s) and/or Protein(s) causing Amyloid Myopathy - Mayo Clinic

    This research is being done to help us better understand the clinical characteristics and to identify gene(s) and/or protein(s) causing these diseases. The ...

  6. Mayo Clinic Year End 2022 Consolidated

    We conducted our audits in accordance with auditing standards generally accepted in the United. States of America (GAAS). Our responsibilities under those ...

  7. Seroprevalence Study of Pre-existing Immunity for Adenovirus-associated Virus Vector in MYBPC3-associated Hypertrophic Cardiomyopathy - Mayo Clinic

    Inclusion Criteria: Signed informed consent. Ages ≥18 to ≤65 years. Diagnosed with HCM per American College of Cardiology (ACC)/American Heart Association ...

  8. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...

  10. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

    Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...